Neuronetics, Inc.
USD1.33
-0.03 (-2.21%)
CEO
Daniel L. Reuvers
IPO Date
2018-06-28
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$1.36
Prev. Close
$1.36
Day Low
$1.32
Day High
$1.40
52W Low
$0.80
52W High
$4.85
Market Cap
$0.09B
Volume
0.19M
| -1.2 |
| 31 Dec 2023 | FY | 72.5% | -42.3% | -88.3% | -26.1% | 1.83 | 4.73 | -2.8 |
| 31 Dec 2022 | FY | 76.3% | -57.0% | -65.1% | -31.8% | 0.70 | 2.98 | -5.0 |
| 31 Dec 2021 | FY | 78.9% | -56.4% | -36.6% | -22.1% | 0.46 | 7.34 | -3.6 |
| 31 Dec 2020 | FY | 76.5% | -55.7% | -107.7% | -34.9% | 1.50 | 4.75 | -7.6 |
| 31 Dec 2019 | FY | 75.4% | -46.4% | -60.7% | -29.0% | 0.72 | 3.19 | -2.8 |
| 31 Dec 2018 | FY | 76.4% | -45.7% | -33.9% | -20.6% | 0.43 | 8.44 | -7.2 |
| 31 Dec 2017 | FY | 76.2% | -39.7% | 8.3% | -41.2% | -0.15 | 3.09 | -0.0 |
| 31 Dec 2016 | FY | 80.7% | -32.8% | 6.3% | -45.3% | -0.11 | 1.72 | -0.0 |
| -3.3 |
| 30 Sept 2025 | Q3 | 45.9% | -24.3% | -33.1% | -6.2% | 3.32 | 2.24 | -5.1 |
| 30 Jun 2025 | Q2 | 46.6% | -26.6% | -37.3% | -7.5% | 2.97 | 2.02 | -5.7 |
| 31 Mar 2025 | Q1 | 49.2% | -39.6% | -35.8% | -8.9% | 2.33 | 2.44 | -4.5 |
| 31 Dec 2024 | Q4 | 66.2% | -56.3% | -45.7% | -9.0% | 2.98 | 1.86 | -1.2 |
| 30 Sept 2024 | Q3 | 75.6% | -72.0% | -142.2% | -18.0% | 5.19 | 3.16 | -0.4 |
| 30 Jun 2024 | Q2 | 74.0% | -59.8% | -50.7% | -10.2% | 3.23 | 2.58 | -1.3 |
| 31 Mar 2024 | Q1 | 75.1% | -45.2% | -28.5% | -7.6% | 2.26 | 5.65 | -4.5 |
| 31 Dec 2023 | Q4 | 77.6% | -26.5% | -15.7% | -4.6% | 1.83 | 4.73 | -3.9 |